Use of ginsenoside Rg3-loaded electrospun PLGA fibrous membranes as wound cover induces healing and inhibits hypertrophic scar formation of the skin
- 1 March 2014
- journal article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 115, 61-70
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Epidemiology and Impact of Scarring After Burn InjuryJournal of Burn Care & Research, 2012
- Photodynamic therapy for a hypertrophic scarring: a promising choicePhotodermatology, Photoimmunology & Photomedicine, 2011
- Ginsenoside Rg3 inhibit hepatocellular carcinoma growthviaintrinsic apoptotic pathwayWorld Journal of Gastroenterology, 2011
- Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment StrategiesMolecular Medicine, 2010
- Gensenoside Rg3 Inhibits Hypoxia-induced VEGF Expression in Human Cancer CellsCellular Physiology and Biochemistry, 2010
- Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in miceBMC Cancer, 2009
- The angiosuppressive effects of 20(R)- ginsenoside Rg3Biochemical Pharmacology, 2006
- Quality of life of patients with keloid and hypertrophic scarringArchives of Dermatological Research, 2006
- In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3Journal of Chromatography B, 2005
- Differentiated Keratinocyte-Releasable Stratifin (14-3-3 Sigma) Stimulates MMP-1 Expression in Dermal FibroblastsJournal of Investigative Dermatology, 2005